Austria’s Miracor Medical Systems is boosting its presence in the U.K. with a new sales office and 2 clinical trials of its heart attack-treatment device.
The maker of the PICSO impulse system said it launched a sales subsidiary in Manchester, U.K., even as a number of providers in the U.K. are already using the device. Miracor CEO Ludwig Gold explained in prepared remarks that the expansion will allow it to serve its existing U.K. customer base but also expand its sales efforts.
Help employers find you! Check out all the jobs and post your resume.
